{"id":"W1991810959","doi":"10.1053/j.gastro.2006.11.041","title":"Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial","year":2006,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2250,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Adalimumab; Medicine; Placebo; Internal medicine; Crohn's disease; Adverse effect; Randomized controlled trial; Gastroenterology; Tumor necrosis factor alpha; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}